JF's analysis may be better than than JG and there are the patent mistakes that a new CEO always makes.
They need remember that Australian FY is not the same as the calendar year.
Also page 20 bad typo to have NDA where it should be FDA.
Patient 2 on page 21 did very well looks headed to a CR. That would be game changing.
Still running out fo cash fast need a rain maker.
Also they need to join the dots to the dollars for investors.
Good luck.
- Forums
- ASX - By Stock
- Ann: Kazia Corporate Update and Corporate Presentation
JF's analysis may be better than than JG and there are the...
-
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
SPONSORED BY The Market Online